Trulife Peptides

Age Verification Required

You must be 21 years of age or older to access this site.

Recovery & Repair

TB-500: Research into Thymosin Beta-4 Fragment, Actin Sequestration, and Cell Migration

Research Disclaimer: This article is intended for educational and scientific reference purposes only. It discusses in vitro research findings and does not constitute medical advice or recommend any therapeutic use. TB-500 is sold by Trulife Peptides strictly for legitimate laboratory research.

What is TB-500?

TB-500 is a synthetic analogue of the active region of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide found at high concentrations in blood platelets, wound fluid, and a wide range of cell types. TB-500 corresponds to the actin-binding domain of Tβ4, specifically the sequence Ac-LKKTETQ (amino acids 17–23), which is responsible for much of the parent molecule's characterized biological activity in vitro.

The isolation of this shorter, active fragment as a research tool has made TB-500 one of the most studied peptides in the tissue repair and cell migration research space, offering a more defined pharmacological handle on Tβ4's mechanisms than the full-length molecule.

Actin Sequestration: The Core Mechanism

The primary characterized molecular function of Thymosin Beta-4 — and by extension TB-500 — is actin sequestration. Actin is the most abundant protein in most eukaryotic cells and exists in two primary forms: globular monomeric actin (G-actin) and filamentous polymerized actin (F-actin). The balance between G-actin and F-actin is tightly regulated and controls cell shape, motility, and division.

TB-500 binds G-actin monomers with high affinity (Kd approximately 0.5 µM for Tβ4), effectively sequestering them and preventing their incorporation into F-actin filaments. This actin sequestration activity has several downstream consequences that researchers study in cell-based models:

Cell Migration Research

Cell migration is one of the most studied in vitro readouts for TB-500 activity. Researchers use several complementary assays to characterize its effects:

Scratch wound assays — A monolayer of cells is scratched with a pipette tip and the rate of scratch closure is measured over time. TB-500-treated cultures are compared to vehicle controls to quantify effects on 2D migration speed and directionality.

Boyden chamber transwell migration assays — Cells are placed in the upper chamber of a transwell insert and TB-500 or vehicle is added to the lower chamber as a chemoattractant. The number of cells migrating through the membrane pores is counted after a fixed time period, providing a directional migration (chemotaxis) readout.

Time-lapse microscopy — Live imaging of individual cell tracks allows quantification of migration velocity, directionality (chemotactic index), and migration mode (mesenchymal vs. amoeboid) in TB-500-treated versus control cells.

These assays have been used across multiple cell types including endothelial cells, fibroblasts, keratinocytes, and smooth muscle cells to build a comprehensive picture of TB-500's cell type-specific effects on migration dynamics.

Angiogenesis and Endothelial Cell Research

Endothelial cell migration is a prerequisite for angiogenesis — the sprouting and extension of new blood vessels from existing vasculature. In HUVEC (human umbilical vein endothelial cell) models and similar endothelial systems, TB-500's pro-migratory effects on actin dynamics have been studied in the context of in vitro angiogenesis assays.

Tube formation assays on Matrigel are commonly used to quantify TB-500's effects on endothelial cell organization into capillary-like structures. Researchers measure total tube length, number of branch points, and network area as indicators of pro-angiogenic activity, comparing TB-500 to positive controls (VEGF) and vehicle.

ILK Pathway Involvement

Beyond actin binding, research has identified involvement of integrin-linked kinase (ILK) in TB-500's cell migration effects. ILK is a serine-threonine kinase at the focal adhesion complex that links integrin receptors to the actin cytoskeleton and regulates migration-related signaling. Studies in endothelial and cardiac cell lines have investigated whether TB-500's effects on cell migration involve ILK upregulation and downstream PI3K/Akt pathway activation, potentially explaining pro-survival and pro-migratory effects beyond direct actin sequestration.

TB-500 and BPC-157 in Combination Research

TB-500 is frequently studied alongside BPC-157 in tissue repair research models, as the two peptides appear to act on complementary mechanisms. TB-500's primary characterized activity is on the actin cytoskeleton and cell migration, while BPC-157's research activity centers on angiogenic signaling and gastric cytoprotection via NO pathway and FAK/paxillin cascades. Together they cover two distinct but synergistic aspects of the tissue repair cascade — providing researchers with a two-peptide experimental design that can illuminate how cytoskeletal remodeling and angiogenesis interact in in vitro wound healing models.

TB-500 10mg — Research Grade

≥99% purity · Third-party HPLC verified · COA included

View Product